The largest database of trusted experimental protocols

22 protocols using anti brdu

1

Immunofluorescence Labeling of Neural Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
First, free-floating sections were washed in PBS three times, followed by incubation in blocking buffer (0.1% Triton X-100, 1% bovine serum albumin, 5% normal goat serum in PBS) for 1 h. Then sections were incubated with primary antibody overnight at 4°C, washed for three times in PBS, and then incubated with secondary antibody for 2 h at 4°C. After 4′,6-diamidino-2-phenylindole (DAPI) treatment for 2 min, sections were washed again with PBS three times and mounted with Fluoromount-G (SouthernBiotech, Birmingham, AL). For BrdU incorporation, sections were treated before standard blocking protocol as follows: incubation with 2N HCl was performed at room temperature for 1 h, followed by soak in 0.1 m (pH 8.4) borate buffer for 10 min. After three washes in PBS, sections were processed according to standard protocol in blocking solution. The primary antibodies and their final concentrations used in the experiments were as follows: anti-BrdU (1:200, rat; AbD Serotec, Raleigh, NC), anti-pS6 (1:200, rabbit; Cell Signaling Technology, Danvers, MA), anti-GFP (1:1000, chicken; Abcam, Cambridge, MA), and anti-Sox2 (1:1000, goat; R&D Systems, Minneapolis, MN). Secondary antibodies were from Jackson ImmunoResearch Laboratories (West Grove, PA) and applied in a 1:1000 dilution.
+ Open protocol
+ Expand
2

Evaluating Cell Proliferation via BrdU Incorporation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine cell proliferations, 5-bromo-2′-deoxyuridine (BrdU, 50 mg/kg body weight; Sigma) incorporation assay was performed. BrdU, as a thymidine analog, is incorporated into newly synthesized DNA during the S phase of cell replication [22] . BrdU was administered to mice beginning on 1 day before cisplatin injection, every other day until sacrifice. Kidney sections were subjected to immunohistochemical staining using anti-BrdU (Serotec, Oxford, UK) antibody. The cortical and outer medullary regions were observed under a Leica microscope (DM2500, Wetzlar, Germany).
+ Open protocol
+ Expand
3

Quantifying Neurogenesis in Aging Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemistry was conducted as previously described [31 (link)]. Briefly, 14- months old mice were overdosed with pentobarbital and transcardially perfused with 0.9% saline solution. Brains were removed and hemispheres were separated. Hemi-brains were placed in 4% paraformaldehyde overnight prior to cryoprotection in increasing sucrose gradients (10%, 20% and 30% each day). Hemi-brains were sectioned horizontally on a freezing microtome at a thickness of 25 µm and stored in phosphate-buffered saline containing 0.02% NaN3 at 4 °C until staining. Six sections containing the hippocampus were selected for staining. Immunofluorescent staining was completed using anti-BrdU (1:200; AbD Serotec) and anti-NeuN (1:100; Millipore) primary antibodies with Alexa Fluor 594 and 633 secondaries (1:1000; Invitrogen). Sections were then mounted in glass slides and allowed to dry overnight, followed by cover-slipping the next day. Slides were scanned into digital images using a Zeiss AxioScan.Z1 slide scanner. Positive staining was determined visually based on morphology and co-localization of BrdU with NeuN and counted by hand for both the dentate gyrus and subventricular zones.
+ Open protocol
+ Expand
4

Immunoblotting and Immunocytochemistry Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rat monoclonal anti-BrdU (#OBT0030; AbDSerotec, Raleigh, NC), rabbit polyclonal anti-cytoskeletal actin (β-actin) (#A300-491A; Bethyl Laboratories, Inc., Montgomery, TX) and mouse monoclonal anti-Ki67 (NCL-Ki67-MM1; Novocastra/Leica Microsystems, Inc., New Castle, UK), rabbit polyclonal to p85 fragment of PARP (#G734A, Promega, Madison, WI) and cyclin B (BD #61029; BD Biosciences, San Jose, CA) were procured from their respective manufacturers. Rabbit polyclonal to cleaved caspase-3 (#9661), p21Cip1/WAF1 (#CS2947), Cdc25C (#CS4648), p-Cdc25C (#CS9528), Cdc2 (#CS9112) and p-Cdc2 (#CS9111) were purchased from Cell Signaling Technology, Inc., Danvers, MA. Antibodies for p53 (#SC-6243), p27kip21 (#SC528), p19 (#SC-71810), cyclin E (#SC481), Cdk2 (#SC6248) and Cdk4 (#SC23896) were all from Santa Cruz Biotechnology Inc., CA. Peroxidase-conjugated secondary (H&L chain-specific) antibodies for Western blots, goat anti-mouse IgG (#401253) and goat anti-rabbit IgG (#401315) were purchased from Calbiochem-Novabiochem Corp., CA. Secondary antibodies for immunocytochemical analyses, Cy3-AffiniPure donkey anti-rat IgG (#712-165-153) and Cy3-AffiniPure goat anti-mouse IgG (#115-165-003) were procured from Jackson Immuno Research Laboratories, Inc., West Grove, PA.
+ Open protocol
+ Expand
5

Immunofluorescence Labeling of Hippocampal Neurogenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Coronal sections of the hippocampal region were used for double immunofluorescence labeling with BrdU/doublecortin (DCX), or BrdU/NeuN. DNA was denatured as described above. Sections were incubated with a mixture of anti-BrdU (1:500, AbD Serotec, Kidlington, UK) with rabbit polyclonal anti-DCX (1:1000, Abcam, Cambridge, UK) or polyclonal rabbit anti-NeuN (1:1000, Millipore-Chemicon, Burlington, MA, USA). Sections were then rinsed in PBS, followed by incubation with a mixture of the secondary antibodies Alexa Fluor 488 goat anti-rat IgG (1:500, Molecular Probes, Eugene, OR, USA) and Alexa Fluor 568 goat anti-rabbit IgG (1:500, Molecular Probes, Eugene, OR, USA) for 1h at RT. Sections were rinsed, and nuclei were counter-stained with NucBlue (Molecular probes, Eugene, OR, USA). Sections were mounted and dehydrated. Slides were cover-slipped using Vectashield Hard Set anti-fade reagent (Vector Laboratories, Burlingame, CA, USA) and stored in darkness at 4 °C. For staining against Reelin, sagittal sections were incubated with mouse monoclonal anti-Reelin (1:2000, Abcam, Cambridge, UK) and then with Alexa Fluor 488 goat anti-mouse IgG (1:500, Molecular Probes, Eugene, OR, USA) as secondary antibody.
+ Open protocol
+ Expand
6

Immunoblotting for Cell Cycle Regulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
Membranes were incubated with antibodies diluted in PBS supplemented with 5% milk protein and incubated, with agitation, overnight at 4°C. Membranes were subjected to 3 × 5 min washes in PBS and incubated in appropriate secondary antibodies for 1 h at room temperature. The antibodies used for immunoblotting were as follows: anti-CDK18 (Santa Cruz Biotechnology: sc-176), anti-pCDK substrate (phosphor-[K/H]pSP) MultiMab rabbit Ab mix (Cell Signalling), anti-Cyclin A, anti-Cyclin E and anti-Cyclin B1 (all from Cell Signaling), anti-Histone H3 pSer10 (27 (link)), anti-CHK1 (Sigma Aldrich), anti-CHK1 pS317 (Cell Signaling), anti-Myc 9B11 clone (Cell Signalling), anti-RAD9 (Abcam and Bethyl laboratories), anti-RPA2 (Calbiochem), anti-RPA2 pT21 (Abcam), anti-RPA2 pS4/8 (Bethyl Laboratories), anti-KAP1 (Bethyl Laboratories), anti-KAP1 pS824 (Bethyl Laboratories), anti-ATRIP (Bethyl Laboratories), anti-ATR (Santa Cruz Biotechnology), anti-Actin (Abcam), anti-ORC2 (Bethyl Laboratories), anti-RAD17 (Bethyl Laboratories), RAD17 (Santa Cruz Biotechnology), anti-BrdU (AbD Serotec and BD), anti-RRM2 (Santa Cruz Biotechnology), HRP-secondary antibodies (DAKO) and Alexa-Fluor antibodies (Invitrogen).
+ Open protocol
+ Expand
7

Dual-Halogenated Thymidine Analog Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
For BrdU detection, see “Immunohistochemistry” Section above. Concerning IdU and CldU immunohistochemistry, sections were washed five times in TBS (Tris-buffered saline), pretreated with 2N HCl for 10 min, then washed five times in TBS. Antibodies were incubated in TBS containing 5% normal donkey serum and 0.25% Triton X-100 (Vega and Peterson, 2005 (link)).
Halogenated thymidine analogs were detected as follows: for IdU using the mouse monoclonal anti-BrdU (BD Biosciences, San Jose, CA, USA; BD 44; 1:500); for CldU using the rat monoclonal anti-BrdU (AbD Serotec, Raleigh, NC, USA; MCA2060; 1:250). Antibody specificity was analyzed in mice that were injected with either IdU or CldU alone. Secondary antibodies used to visualize the antigens were a donkey anti-rat antiserum conjugated to TRITC (CldU) and a donkey anti-mouse antiserum conjugated to Cy2 (IdU), all from Jackson ImmunoResearch (West Grove, PA, USA).
+ Open protocol
+ Expand
8

Immunofluorescence Staining of Cultured Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were fixed in 4% paraformaldehyde and processed for immunostaining as described41 (link). Cells were stained with one of the following antibodies: anti-Iba1 (1:500, Abcam), anti-GFAP (1:500, Millipore), anti-active caspase3 (1:500, R&D Systems), anti-BrdU (1:500, AbD Serotec), anti-p65 (1:500, Abcam) and anti-CD11b (1:500, AbD Serotec). For anti-BrdU staining, fixed cells were incubated with 2 N HCl for 5 min. EdU staining was performed using the Click-iT EdU Alexa Fluor 555 Imaging Kit (Life Technologies) according to the supplier’s protocol. Stained cells were visualized with a fluorescence microscope (Zeiss Axiovert 200M, Zeiss).
+ Open protocol
+ Expand
9

Proliferation dynamics of cSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
After FACS sorting, 1.0 × 104 Calceinlow, Calceinmiddle, and Calceinhigh cSCs, respectively, 4 days after isolation were seeded onto 24-well plates and the numbers of cells per field were counted every day. For BrdU assay, cSCs 4 days after isolation were treated with 10 μM BrdU (Sigma Aldrich) in DMEM (high glucose, sodium pyruvate, and GlutaMAX supplement) supplemented with 20% FBS, 1% CEE, and 1% PS at 37 °C with 5% CO2 for 2 h. The cells were then treated with 50 nM calcein-AM followed by FACS sorting. Sorted Calceinlow, Calceinmiddle, and Calceinhigh cSCs were fixed with 4% paraformaldehyde/phosphate-buffered saline (PBS). After washing, fixed cells were treated with 0.1% Triton X-100/PBS for 10 min for permeabilization, followed by 2 N HCl for 30 min at room temperature, blocking with 5% goat serum (Cedarlane) in 2% bovine serum albumin (BSA)/PBS for 15 min, and incubation with anti-BrdU (1:400, clone: BU1/75 (ICR1); AbD Serotec) in 2% BSA/PBS at 4 °C overnight. After washing, the cells were incubated with Alexa Fluor 488-labelled secondary antibody (1:1000; Thermo Fisher Scientific) in 1% BSA/PBS. After several washings, nuclei were stained with DAPI (Dojindo). Immunofluorescent-staining images were evaluated by fluorescence microscopy (Olympus IX71), and the percentage of BrdU-positive cells was counted.
+ Open protocol
+ Expand
10

BrdU Labeling of Proliferative Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rats received an intraperitoneal injection of 5-bromo-2-deoxyuridine (BrdU; 50 mg/kg; Sigma-Aldrich) once daily for 10 days, beginning at 3 weeks post-HI injury. Brain sections (40 µm) were stained with anti-BrdU (1:400; Serotec, Oxford, UK) overnight at 4°C, followed by FITC-conjugated secondary antibodies (1:500; Vector Laboratories, Inc., Burlingame, CA, USA). The nuclei were stained with DAPI (molecular probe). The fluorescent images were obtained with a Zeiss LSM 700 laser scanning confocal device (Carl Zeiss, Jena, Germany). Quantification of immunofluorescene was conducted using the iSolution full image analysis software (Image & Microscope Technology).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!